SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-11-348054
Filing Date
2011-12-21
Accepted
2011-12-21 08:15:55
Documents
3
Period of Report
2011-12-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d273008d8k.htm 8-K 18407
2 PRESS RELEASE d273008dex991.htm EX-99.1 9341
3 GRAPHIC g273008image001.jpg GRAPHIC 11125
  Complete submission text file 0001193125-11-348054.txt   44418
Mailing Address 11085 NORTH TORREY PINES ROAD SUITE 300 LA JOLLA CA 92037
Business Address 11085 NORTH TORREY PINES ROAD SUITE 300 LA JOLLA CA 92037 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33093 | Film No.: 111273365
SIC: 2834 Pharmaceutical Preparations